시장보고서
상품코드
1266316

세계의 동물용 신속 진단 검사 시장(-2030년) : 제품(키트, 리더), 증상(바이러스 감염, 기생충 감염, 세균 감염), 동물(반려동물, 가축), 최종사용자(진료소 및 병원, 표준 실험실, 가정)별

Veterinary Rapid Diagnostic Tests Market by Product (Kits, Readers), Condition (Viral, Parasitic, Bacterial Infections), Animal (Companion, Livestock), and End User (Clinics & Hospitals, Reference Labs, Home Testing) - Global Forecast to 2030

발행일: | 리서치사: Meticulous Research | 페이지 정보: 영문 181 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

동물용 신속 진단 검사 시장 규모는 2023년부터 2030년까지 CAGR 8.1%로 추정되며, 2030년에는 11억 달러 규모로 성장할 것으로 예측됩니다.

시장 성장은 인수공통감염증 증가, 기타 검사 방법 보다 뛰어난 신속 검사의 이점, 가정이나 농장에서의 검사에 대한 선호 상승, 동물 건강에 관한 인식 확산, 세계의 동물 의료비 증가, 동물성 식품에 대한 수요 증가 등의 요인에 의해 견인되고 있습니다. 또한 신흥 시장이나 애완동물 사육 급증도 시장에 큰 성장 기회를 생성하고 있습니다.

세계의 동물용 신속 진단 검사 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 내역, 경쟁 환경, 주요 기업 개요 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 인사이트

  • 개요
  • 시장 성장에 영향을 미치는 요인
  • 규제 분석
  • 가격 분석

제5장 동물용 신속 진단 검사 시장 평가 : 제품별

  • 개요
  • 신속 검사 키트
  • 신속 검사 리더

제6장 동물용 신속 진단 검사 시장 평가 : 동물 유형별

  • 개요
  • 반려동물
    • 고양이
    • 기타
  • 가축

제7장 동물용 신속 진단 검사 시장 평가 : 증상별

  • 개요
  • 바이러스 감염
  • 세균 감염
  • 기생충 감염
  • 기타

제8장 동물용 신속 진단 검사 시장 평가 : 최종사용자별

  • 개요
  • 동물 병원·진료소
  • 표준 실험실
  • 가정·농장 시험

제9장 동물용 신속 진단 검사 시장 평가 : 지역별

  • 개요
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 분석

  • 개요
  • 주요 성장 전략
  • 경쟁 벤치마킹
  • 시장 점유율 분석
  • 경쟁 대시보드

제11장 기업 개요

  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Heska Corporation
  • Virbac
  • Woodley Equipment Company Ltd.
  • Thermo Fisher Scientific Inc.
  • Fassisi GmbH
  • MEGACOR Diagnostik GmbH
  • BioNote, Inc.
  • Biopanda Reagents Ltd.

제12장 부록

KSM 23.05.08

Veterinary Rapid Diagnostic Tests Market by Product (Kits, Readers), Condition (Viral, Parasitic, Bacterial Infections), Animal (Companion [Dogs, Cats], Livestock), and End User (Clinics & Hospitals, Reference Labs, Home Testing)- Global Forecast to 2030

The veterinary rapid diagnostic tests market is expected to reach $1.10 billion by 2030, at a CAGR of 8.1% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of the veterinary rapid diagnostic tests market is attributed to the increasing prevalence of zoonotic diseases, the advantages of rapid tests over other testing methods, the growing preference for at-home and farm testing, rising awareness regarding veterinary health and increasing global animal health expenditure, and the increasing demand for animal-derived food products. Furthermore, emerging markets and a surge in pet ownership offers significant growth opportunities for the market.

Based on product, the rapid test kits segment is expected to grow at a faster CAGR during the forecast period. The growth of this segment is attributed to the recurring usage of test kits, the growing prevalence of diseases in animals, and increasing the preference of farmers for at-farm testing. Rapid tests enable near-animal testing, helping farmers avoid transporting large animals to veterinary establishments, which can be expensive and inconvenient. Moreover, the transport of lab samples to the laboratories poses a risk of damaging a sample causing alteration of test results and is time-consuming, depending on the technique used for testing in the laboratory.

Based on condition, the viral infections segment is expected to grow at the highest CAGR during the forecast period. The factors responsible for the growth are increasing viral infection outbreaks in animals, the focus of authorities to monitor and control disease outbreaks in animals globally, and the risk of viral infections of cross-species barrier and infections in humans.

Based on animal type, in 2023, the companion animals segment is expected to account for the largest share of the global veterinary rapid diagnostic tests market. The large share of this segment is attributed to the large population base of pets globally, high awareness regarding regular checkups and testing in pet owners, and increasing pet care expenditure.

Based on end user, in 2023, the veterinary hospitals & clinics segment is expected to account for the largest share of the global veterinary rapid diagnostic tests market. Veterinary hospitals & clinics are preferred and generally the first choice by pet owners and farmers for health checkups and disease testing. The easy accessibility to veterinary hospitals and clinics in developing countries also contributes to the large share of the segment.

An in-depth analysis of the geographical scenario of the veterinary rapid diagnostic tests market provides detailed qualitative and quantitative insights into five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the global veterinary rapid diagnostic tests market, while Asia-Pacific is expected to record the highest CAGR during the forecast period. The high growth of the Asia-Pacific veterinary rapid diagnostic tests market is attributed to the large population of livestock animals and the rising incidence of various zoonotic diseases in the region.

Some of the key players operating in the global veterinary rapid diagnostic tests market are EXX Laboratories, Inc. (U.S.), Zoetis Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Woodley Equipment Company Ltd. (U.K.), Virbac (France), Heska Corporation (U.S.), SWISSAVANS AG (Switzerland), Fassisi GmbH (Germany), MEGACOR Diagnostik GmbH (Austria), and BioNote, Inc. (South Korea).

Scope of the Report:

Veterinary Rapid Diagnostic Tests Market Assessment, by Product

  • Rapid Test Kits
  • Rapid Test Readers

Veterinary Rapid Diagnostic Tests Market Assessment, by Condition

  • Viral Infections
  • Bacterial Infections
  • Parasitic Infections
  • Other Conditions

(The other conditions segment covers metabolic diseases and ailments, pregnancy tests, and optimum breeding time).

Veterinary Rapid Diagnostic Tests Market Assessment, by Animal Type

  • Companion Animals
  • Dogs
  • Cats
  • Other Companion Animals

(The other companion animal segment covers rabbits, birds, fish, reptiles, and other small animals).

  • Livestock Animals

Veterinary Rapid Diagnostic Tests Market Assessment, by End User

  • Reference Laboratories
  • Veterinary Hospitals & Clinics
  • At-home/Farm Testing

Veterinary Rapid Diagnostic Tests Market Assessment, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Ecosystem
  • 1.2. Currency and Limitations
  • 1.3. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary research / Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Factor Analysis
  • 4.3. Veterinary Rapid Diagnostic Tests Market: Regulatory Analysis
    • 4.3.1. North America
      • 4.3.1.1. U.S.
      • 4.3.1.2. Canada
    • 4.3.2. Europe
    • 4.3.3. Asia-Pacific
      • 4.3.3.1. India
      • 4.3.3.2. China
      • 4.3.3.3. Japan
    • 4.3.4. Middle East
      • 4.3.4.1. Saudi Arabia
  • 4.4. Global Veterinary Rapid Diagnostic Tests Market: Pricing Analysis
    • 4.4.1. Viral Infection Tests
    • 4.4.2. Bacterial Infection Tests
    • 4.4.3. Parasitic Infection Tests
    • 4.4.4. Rapid Diagnostic Tests for Other Conditions

5. Veterinary Rapid Diagnostic Tests Market Assessment, By Product

  • 5.1. Overview
  • 5.2. Rapid Test Kits
  • 5.3. Rapid Test Readers

6. Veterinary Rapid Diagnostic Tests Market Assessment, By Animal Type

  • 6.1. Overview
  • 6.2. Companion Animals
    • 6.2.1. Dogs
    • 6.2.2. Cats
    • 6.2.3. Other Companion Animals
  • 6.3. Livestock

7. Veterinary Rapid Diagnostic Tests Market Assessment, By Condition

  • 7.1. Overview
  • 7.2. Viral Infections
  • 7.3. Bacterial Infections
  • 7.4. Parasitic Infections
  • 7.5. Other Conditions

8. Veterinary Rapid Diagnostic Tests Market Assessment, By End User

  • 8.1. Overview
  • 8.2. Veterinary Hospitals & Clinics
  • 8.3. Reference Laboratories
  • 8.4. At-Home/Farm Testing

9. Veterinary Rapid Diagnostic Tests Market Assessment, By Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competition analysis

  • 10.1. OVERVIEW
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis (2022)
    • 10.4.1. IDEXX Laboratories, Inc. (U.S.)
    • 10.4.2. Zoetis Inc. (U.S.)
    • 10.4.3. Heska Corporation (U.S.)
    • 10.4.4. Virbac (France)
  • 10.5. Competitive Dashboard
    • 10.5.1. Industry Leaders
    • 10.5.2. Market Differentiators
    • 10.5.3. Vanguards
    • 10.5.4. Emerging Companies

11. Company Profiles

  • 11.1. IDEXX Laboratories, Inc.
    • 11.1.1. Business Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
    • 11.1.4. Swot Analysis
  • 11.2. Zoetis Inc.
    • 11.2.1. Business Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Developments
    • 11.2.5. Swot Analysis
  • 11.3. Heska Corporation
    • 11.3.1. Business Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
    • 11.3.4. strategic developments
    • 11.3.5. Swot Analysis
  • 11.4. Virbac
    • 11.4.1. Business Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
    • 11.4.4. Swot Analysis
  • 11.5. Woodley Equipment Company Ltd.
    • 11.5.1. Business Overview
    • 11.5.2. Product Portfolio
    • 11.5.3. Swot Analysis
  • 11.6. Thermo Fisher Scientific Inc.
    • 11.6.1. Business Overview
    • 11.6.2. Financial Overview
    • 11.6.3. Product Portfolio
  • 11.7. Fassisi GmbH
    • 11.7.1. Business Overview
    • 11.7.2. Product Portfolio
    • 11.7.3. Strategic Developments
  • 11.8. MEGACOR Diagnostik GmbH
    • 11.8.1. Business Overview
    • 11.8.2. Product Portfolio
    • 11.8.3. Strategic Developments
  • 11.9. BioNote, Inc.
    • 11.9.1. Business Overview
    • 11.9.2. Product Portfolio
    • 11.9.3. Strategic Developments
  • 11.10. Biopanda Reagents Ltd.
    • 11.10.1. Business Overview
    • 11.10.2. Product Portfolio

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제